Ann: Macy Scoping Study Update, page-59

First 59 Last

Share
Profile

Follow
red-frog

1,712 Posts.

177

24/08/18

23:02

Post #: 35171927
Share

Originally posted by dunny29 ↑

Some of those that took part in the cap raise were happy to sell heads at a profit and even a loss to around 2.5c based on the broker data I've been told. From 2.5c below has generally been retail.

The point I'm making is that I don't think that the oppies are being pumped to sell them, I think they are genuinely being held tight by those in the cap raise. They are not only effectively free carrying them through selling heads (if they did as usually tends to happen), they may also see the company being valued much higher soon, so have held oppies as they still provide significant upside (which often generally happens in raisings of this style).

This is forcing investors to pay up to ensure they get them, at a price they still see great value at, even if they are obviously out of sync with the heads. Although every pip lower is very significant at these levels, there is simply too many people wanting them and so few available to allow them to drop to a level we would expect.

Waiting for a drop on oppies to a level that you would normally expect with the numbers involved here may end up being futile based on the supply/demand that we've seen so far. I've seen this pattern emerge a couple of times, generally 6 or so months later, holders were very happy.

Expand

I don't know what's going on with the oppies, but I like the heads at 2c or less.

SL1 Price at posting: 2.0¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Dreadnought achieves 84% indicated resource at Star of Mangaroon

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 283 more messages in this thread...

First 59 Last

Add SL1 (ASX) to my watchlist

Ann: Macy Scoping Study Update, page-59

Top Stories

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Dreadnought achieves 84% indicated resource at Star of Mangaroon

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game